No Data
No Data
Insider Sale: CHIEF MEDICAL OFFICER of $STOK (STOK) Sells 13,945 Shares
Express News | Cantor Fitzgerald Reiterates Overweight on Stoke Therapeuticsto Overweight
Stoke Therapeutics Analyst Ratings
Stoke Therapeutics: Promising Developments in Seizure Treatment Bolster Buy Rating
Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $22
H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35